| 摘要 |
Included in the disclosure is description of a method of determining a presence, and/or aggressiveness level, and/or response to therapy of a human disease in a subject. The method involves determining size of nanoparticles upon being exposed to a biological sample or a component of biological sample or pretreated biological sample from the subject to form an assay solution, wherein the average particle size of the assay solution is correlative to the presence, and/or aggressiveness level, and/or response to therapy of disease in said subject
|
